Ansuvimab
http://dbpedia.org/resource/Ansuvimab an entity of type: Thing
Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of Zaire ebolavirus (Ebolavirus) infection. The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection. Ansuvimab was approved for medical use in the United States in December 2020.
rdf:langString
rdf:langString
Ansuvimab
xsd:integer
58757469
xsd:integer
1090912877
rdf:langString
None
xsd:integer
6368
xsd:integer
2375952
rdf:langString
DB16385
xsd:integer
9924
rdf:langString
D11875
rdf:langString
Rx-only
xsd:integer
1724
xsd:integer
1994
xsd:integer
44
rdf:langString
u
rdf:langString
Ansuvimab-zykl, mAb114
rdf:langString
Zaire ebolavirus
rdf:langString
Ebanga
rdf:langString
mab
rdf:langString
TG8IQ19NG2
rdf:langString
Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of Zaire ebolavirus (Ebolavirus) infection. The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection. Ansuvimab was approved for medical use in the United States in December 2020.
rdf:langString
Ansuvimab
rdf:langString
mab
xsd:nonNegativeInteger
25207
rdf:langString
Ebanga
xsd:string
2375952-29-5
xsd:string
DB16385
xsd:string
TG8IQ19NG2
xsd:string
D11875